CAS 219832-49-2

MP-A08

CAS : 219832-49-2

MP-A08 selectively inhibits SPHK1; targets SphK1 & SphK2 with Ki of 6.9 μM & 27 μM, respectively.

Formule : C₂₇H₂₅N₃O₄S₂

Degré de pureté : 97.44%

Couleur et forme : Solid

Masse moléculaire : 519.64

Ref: TM-T16128

MP-A08

CAS : 219832-49-2

Formule : C₂₇H₂₅N₃O₄S₂

Degré de pureté : 97%

Couleur et forme : Solid

Masse moléculaire : 519.6351

Ref: IN-DA00BF7P

MP-A08

CAS : 219832-49-2

MP-A08

Degré de pureté : ≥95%

Masse moléculaire : 519.64g/mol

Ref: 54-BUP13155

MP-A08

CAS : 219832-49-2

MP-A08 is a potent inhibitor drug that blocks the activity of epidermal growth factor receptor (EGFR). It has been shown to inhibit the growth of cancer cells in vitro and in vivo. MP-A08 was also found to have synergistic effects with cancer drugs, such as doxorubicin, cisplatin, 5-fluorouracil, and tamoxifen. MP-A08 may be used for the treatment of cardiac and prostate cancer.

Formule : C₂₇H₂₅N₃O₄S₂

Degré de pureté : Min. 95%

Masse moléculaire : 519.64 g/mol

Ref: 3D-UIA83249